CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis

被引:20
作者
Wang, Bin [1 ,2 ]
Yan, Lifang [3 ]
Shi, Weihong [3 ]
Xie, Han [4 ]
Chen, Ruixiong [4 ]
Shao, Yanqing [2 ]
Liang, Weiguo [1 ]
机构
[1] Jinan Univ, Dept Orthoped, Guangzhou Red Cross Hosp, 396 Tongfu Middle Rd, Guangzhou 510220, Guangdong, Peoples R China
[2] Huizhou First Hosp, Dept Orthoped, Huizhou 516003, Guangdong, Peoples R China
[3] Guangzhou Univ Tradit Chinese Med, Dept Oncol, Huizhou Hosp, Huizhou 516001, Guangdong, Peoples R China
[4] Huizhou Cent Peoples Hosp, Dept Orthoped, Huizhou 516008, Guangdong, Peoples R China
关键词
Osteosarcoma; CircRNA PVT1; MiR-24-3p; KLF8; Proliferation; Chemoresistance; LUNG-CANCER; INVASION; CONTRIBUTES; RESISTANCE; APOPTOSIS; CIRCPVT1; UPDATE; RNA;
D O I
10.1007/s10147-022-02122-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective To investigate the regulatory effect and mechanism of circular RNA PVT1 (circPVT1) in proliferation and chemoresistance of osteosarcoma (OS) cells. Methods The expression of circPVT1 in human OS and adjacent normal tissues was detected. The correlation between circPVT1 expression and clinical features of OS was analyzed. The expressions of circPVT1 and miR-24-3p in OS cells resistant to cisplatin, doxorubicin or methotrexate and parental OS cells were detected after cell transfection. CCK-8 and colony formation assay assessed the viability and proliferative ability of OS cells. qRT-PCR and Western blotting measured the expression of KLF8. Dual-luciferase reporter and RNA pull-down assays verified the targeting relationships of circPVT1/miR-24-3p and miR-24-3p/KLF8. Results CircPVT1 was over-expressed in OS tissues and cells, and correlated with clinical features of OS. Over-expressed circPVT1 reduced the survival of OS patients. CircPVT1 was up-regulated in chemoresistant OS cells compared to their parental cells. CircPVT1 inhibition suppressed the proliferation and chemoresistance of OS cells. MiR-24-3p was under-expressed in OS cells and further down-regulated in chemoresistant cells. CircPVT1 could bind and down-regulate miR-24-3p. MiR-24-3p overexpression inhibited the proliferation and chemoresistance of OS cells. KLF8 was over-expressed in OS cells and further up-regulated in chemoresistant cells. MiR-24-3p negatively regulated the expression of KLF8. Conclusion CircPVT1 mediates proliferation and chemoresistance of OS cells via the miR-24-3p/KLF8 axis. The findings may provide guidance for clinical treatment of OS.
引用
收藏
页码:811 / 822
页数:12
相关论文
共 30 条
  • [1] Update on Survival in Osteosarcoma
    Anderson, Megan E.
    [J]. ORTHOPEDIC CLINICS OF NORTH AMERICA, 2016, 47 (01) : 283 - +
  • [2] Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
    Anninga, Jakob K.
    Gelderblom, Hans
    Fiocco, Marta
    Kroep, Judith R.
    Taminiau, Anstoni H. M.
    Hogendoorn, Pancras C. W.
    Egeler, R. Maarten
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 (16) : 2431 - 2445
  • [3] Bone Cancer Clinical Practice Guidelines in Oncology
    Biermann, J. Sybil
    Adkins, Douglas R.
    Agulnik, Mark
    Benjamin, Robert S.
    Brigman, Brian
    Butrynski, James E.
    Cheong, David
    Chow, Warren
    Curry, William T.
    Frassica, Deborah A.
    Frassica, Frank J.
    Hande, Kenneth R.
    Hornicek, Francis J.
    Jones, Robin L.
    Mayerson, Joel
    McGarry, Sean V.
    McGrath, Brian
    Morris, Carol D.
    O'Donnell, Richard J.
    Randall, R. Lor
    Santana, Victor M.
    Satcher, Robert L.
    Siegel, Herrick J.
    von Mehren, Margaret
    Bergman, Mary Anne
    Sundar, Hema
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (06): : 688 - 723
  • [4] Chen PC., 2014, Biomed. Res. Int, V2014
  • [5] An update on chemotherapy for osteosarcoma
    Ferrari, Stefano
    Serra, Massimo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (18) : 2727 - 2736
  • [6] Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior
    Gao, Yang
    Liu, Yimin
    Du, Lutao
    Li, Juan
    Qu, Ailin
    Zhang, Xin
    Wang, Lili
    Wang, Chuanxin
    [J]. MEDICAL ONCOLOGY, 2015, 32 (01)
  • [7] Current and future therapeutic approaches for osteosarcoma
    Harrison, Douglas J.
    Geller, David S.
    Gill, Jonathan D.
    Lewis, Valerae O.
    Gorlick, Richard
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (01) : 39 - 50
  • [8] Translational biology of osteosarcoma
    Kansara, Maya
    Teng, Michele W.
    Smyth, Mark J.
    Thomas, David M.
    [J]. NATURE REVIEWS CANCER, 2014, 14 (11) : 722 - 735
  • [9] Circular RNAs in cancer: opportunities and challenges in the field
    Kristensen, L. S.
    Hansen, T. B.
    Veno, M. T.
    Kjems, J.
    [J]. ONCOGENE, 2018, 37 (05) : 555 - 565
  • [10] Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
    Lilienthal, Ingrid
    Herold, Nikolas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 56